Safety and Tolerability of Anti-IL-20 in Healthy Volunteers and Patients With Rheumatoid Arthritis

NCT00818064 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation
Rheumatoid Arthritis
Healthy

Interventions

DRUG: anti-IL-20
DRUG: placebo

Sponsor

Novo Nordisk A/S